Synthesis, psychotropic and anticancer activity of 2,2-dimethyl-5-[5′ -trialkylgermyl(silyl)-2′-hetarylidene]-1,3-dioxane-4,6-diones and their analogues

Applied Organometallic Chemistry

Volumn 17, Issue 12, 2003, Pages 898-905

  Lukevics, Edmunds ^a   Ignatovich, Luba ^a   Shestakova, Irina ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

2,2 Dimethyl 5 furfurylidene 1,3 dioxane 4,6 dione; 2,2 Dimethyl 5 thenylidene 1,3 dioxane 4,6 dione; Cytotoxicity; Organoger manium compounds; Organosilicon compounds; Psychotropic activity; Toxicity

Indexed keywords

2,2 DIMETHYL 5 (5' THIENYLIDENE) 1,3 DIOXANE 4,6 DIONE; 2,2 DIMETHYL 5 (5' TRIETHYLSILYL 2' THIENYLIDENE) 1,3 DIOXANE 4,6 DIONE; 2,2 DIMETHYL 5 [5' GERMYL(SILYL) 2' THIENYLIDENE] 1,3 DIOXANE 4,6 DIONE DERIVATIVE; FURAN DERIVATIVE; GERMANIUM DERIVATIVE; HETEROCYCLIC COMPOUND; INORGANIC COMPOUND; MELDRUM ACID; SILANE DERIVATIVE; SILICON DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NEUROTROPIC ACTIVITY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOTROPIC ACTIVITY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 0344305770     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/aoc.560     Document Type: Article

References (29)

1. Davidson D, Bernhard SA. J. Am. Chem. Soc. 1948; 70: 3974.
2. Schuster P, Polansky OE, Wessely F. Monatsh. Chem. 1964; 95: 53.
3. Bihlmayer GA, Derflinger G, Derkosch J, Polansky OE. Monatsh. Chem. 1967; 98: 565.
4. Baxter GJ, Brown RFC. Aust. J. Chem. 1975; 28: 1551.
5. Dauben WG, Kozikowski AP, Zimmerman WT. Tetrahedron Lett. 1975; 8: 515.
6. Herzog U, Reinshagen H. Eur. J. Med. Chem. Chim. Therap. 1976; 11: 415.
7. McNab H. Chem. Soc. Rev. 1978; 7: 345.
8. Krapivin GD, Kul'nevich VG, Val'ter NI. Chem. Heterocycl. Compd. 1986; 22: 1072.
9. Krapivin GD, Zavodnik VE, Bel'skii VK, Val'ter NI, Kul'nevich VG. Chem. Heterocycl. Compd. 1988; 24: 1200.
10. Krapivin GD, Zavodnik VE, Val'ter NI, Bel'skii VK, Kul'nevich VG. Chem. Heterocycl. Compd. 1989; 25: 1005.
11. Krapivin GD, Kul'nevich VG, Val'ter NI. Chem. Heterocycl. Compd. 1989; 25: 1118.
12. Krapivin GD, Val'ter NI, Kaklyugina TYa, Kul'nevich VG. Chem. Heterocycl. Compd. 1994; 30: 289.
13. Krapivin GD, Val'ter NI, Zavodnik VE, Vegkh D, Fishera L, Kul'nevich VG. Chem. Heterocycl. Compd. 1995; 31: 782.
14. Yavari I, Nori-Shargh D, Fallah-Bagher-Shaidaii H. J. Chem. Research (S) 1996; 146.
15. Couturier D, Rigo B. J. Heterocycl. Chem. 1999; 36: 1073.
16. Šafar P, Považanec F, Pronayova N, Baran P, Kickelbick G, Kožišek J, Breza M. Collect. Czech. Chem. Commun. 2000; 65: 1911.
17. Bigi F, Carloni S, Ferrari L, Maggi R, Mazzacani A, Sartori G. Tetrahedron Lett. 2001; 42: 5203.
18. Kaupp G, Naimi-Jamal MR, Schmeyers J. Tetrahedron 2003; 59: 3753.
19. Kleeman A, Engel J, Kutscher B, Reichert D. Pharmaceutical Substances. Thieme: Stuttgart, 1999.
20. Lukevics E, Ignatovich L. Appl. Organometal. Chem. 1992; 6: 113.
21. Teitze LF, Beifuss U. In Comprehensive Organic Synthesis, vol. 2, Trost BM, Fleming I, Heathcock CH (eds). Pergamon Press: Oxford, 1991; 341-394.
22. Pita B, Sotelo E, Saurez M, Ravina E, Ochoa E, Verdecia Y, Novoa H, Blaton N, de Ranter C, Peeters OM. Tetrahedron 2000; 56: 2473.
23. Denat F, Gaspard-Iloughmane H, Dubac J. Synthesis 1992; 10: 954.
24. Lukevics E, Ignatovich LM, Goldberg YS, Shimanska MV. Chem. Heterocycl. Compd. 1986; 22: 678.
25. Girodier LD, Maignan ChS, Rouessac FP. Tetrahedron Asymm. 1995; 8: 2045.
26. Vogel HG, Vogel WH. In Drug Discovery and Evaluation (Pharmacological Assays). Springer Verlag: Berlin, 1997; 204.
27. Germane SK, Eberlinjsh OE, Kozhuhov AN. In Scientific and Methodological Aspects of Biological Study of Novel Drugs. Zinatne: Riga, 1987; 86.
28. Fast DJ, Lynch RC, Leu RW. J. Leuckocyt. Biol. 1992; 52: 255.
29. Freshney PJ. Culture of Animal Cells (A Manual of Basic Technique). Wiley-Liss: New York, 1994; 29.